Symbol="PSTX"
AssetType="Common Stock"
Name="Poseida Therapeutics Inc"
Description="Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for patients with high unmet medical needs. The company is headquartered in San Diego, California."
CIK="1661460"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="9390 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="141444000"
EBITDA="-37212000"
PERatio="None"
PEGRatio="None"
BookValue="1.816"
DividendPerShare="0"
DividendYield="0"
EPS="-0.36"
RevenuePerShareTTM="1.79"
ProfitMargin="-0.321"
OperatingMarginTTM="-0.305"
ReturnOnAssetsTTM="-0.0946"
ReturnOnEquityTTM="-0.343"
RevenueTTM="139400000"
GrossProfitTTM="-22407000"
DilutedEPSTTM="-0.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="6.21"
AnalystTargetPrice="13.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.525"
PriceToBookRatio="2.265"
EVToRevenue="1.988"
EVToEBITDA="-16.1"
Beta="0.121"
num_52WeekHigh="8.82"
num_52WeekLow="1.54"
num_50DayMovingAverage="2.053"
num_200DayMovingAverage="4.089"
SharesOutstanding="86776000"
DividendDate="None"
ExDividendDate="None"
symbol="PSTX"
open="1.60"
high="1.69"
low="1.60"
price="1.63"
volume="328789.00"
latest_trading_day="2023-08-04"
previous_close="1.62"
change="0.01"
change_percent="0.6173%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="810705"
Change_recent_avg="-0.03"
Delta_recent_avg="0.22"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-1.36"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="511"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0094.jpeg"
image_negative_thumbnail_id_2="1130"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0163.jpeg"
image_neutral_thumbnail_id_1="540"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="1002"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0164.jpeg"
image_positive_thumbnail_id_2="951"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
